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Background: There are few prospective evaluations of point-of-care ultrasonography (US) for the diagnosis of
pediatric community-acquired pneumonia (CAP). In particular, there are very few data concerning the efficiency of
US in comparison with that of chest radiography (CR) in defining different kinds of lung alterations in the various
pulmonary sections. The aim of this study was to bridge this gap in order to increase our knowledge of the
performance of US in diagnosing CAP in childhood.
Methods: A total of 103 children (56 males, 54.4%; mean age ± standard deviation 5.6 ± 4.6 years) admitted to
hospital with a clinical diagnosis of suspected CAP were prospectively enrolled and underwent CR (evaluated by an
independent expert radiologist) and lung US (performed by a resident in paediatrics with limited experience in US).
The performance of US in diagnosing CAP (i.e. its sensitivity, specificity, and positive and negative predictive values)
was compared with that of CR.
Results: A total of 48 patients had radiographically confirmed CAP. The sensitivity, specificity, and positive and
negative predictive values of US in comparison with CR were respectively 97.9%, 94.5%, 94.0% and 98.1%. US
identified a significantly higher number of cases of pleural effusion, but the concordance of the two methods in
identifying the type of CAP was poor.
Conclusion: US can be considered a useful means of diagnosing CAP in children admitted to an Emergency
Department with a lower respiratory tract infection, although its usefulness in identifying the type of lung
involvement requires further evaluation.
Keywords: Chest radiography, Community-acquired pneumonia, Lower respiratory tract infection, Lung
ultrasonography, Pneumonia, RadiologyBackground
The incidence of community-acquired pneumonia (CAP)
has significantly decreased in places where pneumococcal
conjugate vaccines are widely used [1]. However, it is still a
very frequent cause of morbidity among children aged ≤5
years living in industrialised countries, where its incidence
is about 10–40 cases per 1,000 subjects [2-4]. Most infants
and children with CAP present with a number of clinical
signs and symptoms, such as fever, cough and tachypnea,
and recently published guidelines say that the diagnosis of
mild to moderate cases of pediatric CAP can be based* Correspondence: susanna.esposito@unimi.it
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unless otherwise stated.solely on clinical criteria without having to be confirmed
by chest radiography (CR), which is reserved for severe
cases leading to hospital admission or when complications
are suspected [5-7]. On the other hand, although CR has
some major limitations (including exposure to ionising
radiation and a high degree of inter- and intra-observer
variability in interpretation) [8], the absence of CR con-
firmation leads to the incidence of CAP being largely
overestimated and causes a number of problems, the
most important of which is an increased use of unneces-
sary antibiotics.
In an attempt to overcome this problem, the use of ultra-
sonography (US) was suggested in 1986, when Weinberg
et al. described a new method of evaluating CAP by means
of the demonstration of sonographic air bronchogramsl Ltd. This is an Open Access article distributed under the terms of the Creative
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considered to be reliable and safe, its use was long confined
to a supplementary role in the case of complex CAP,
mainly because there were no portable or hand-held ma-
chines. It is only recently that technological advances have
allowed these difficulties to be overcome and revived inter-
est in using US to diagnose lower respiratory tract infec-
tions. A number of studies have shown that it is feasible
and accurate in diagnosing lung infections when used by
experienced clinician-sonologists [10-17], but there are few
prospective evaluations of point-of-care US for the diagno-
sis of pediatric CAP. In particular, there are very few data
concerning the efficiency of US in comparison with that of
CR in defining different kinds of lung alterations in the
various pulmonary sections.
The aim of this study was to bridge this gap in order
to increase our knowledge of the performance of US in
diagnosing CAP.
Methods
Study design and patients
This prospective observational study was carried out
in Pediatric Highly Intensive Care Unit of the Depart-
ment of Pathophysiology and Transplantation of the
University of Milan between 1 November 2012 and 28
February 2013. It was approved by the Ethics Committee
of Milan’s Fondazione IRCCS Ca’ Granda, Ospedale
Maggiore Policlinico, and required the written informed
consent of a parent or legal guardian; the older children
were asked to give their assent.
All of the otherwise healthy children born at term aged
between 1 month and 14 years admitted with fever (i.e. an
axillary temperature of >38°C) and signs and symptoms
consistent with CAP (i.e. cough, tachypnea, dyspnea or
respiratory distress, and breathing with grunting or wheez-
ing sounds with rales) and hospitalized in our pediatric
ward were considered eligible for inclusion. The patients
who arrived in the Emergency Department with a chest
radiograph previously taken in another hospital and those
with hemodynamic instability were excluded.
Radiological examinations
Upon enrolment, all of the children with suspected CAP
underwent CR, both postero-anterior and lateral views
as recommended in recently published guidelines [6]. The
radiographs were evaluated by an independent expert radi-
ologist (IB), who classified the findings as alveolar pneumo-
nia, non-alveolar (interstitial) pneumonia, mixed interstitial
and alveolar pneumonia, or no pneumonia in accordance
with the World Health Organisation (WHO) criteria for
the standardised interpretation of pediatric chest radio-
graphs for the diagnosis of pneumonia [18]. Immediately
after CR, in all of the patients lung US evaluation of the
lungs was performed.The physician performing lung US was always the
same (SSP), was a resident in paediatrics and had limited
experience in US prior to the study. He had no contact
with the radiologist, and was blinded to the CR findings.
Before starting the study, he underwent a one-day lung
US training session (given by IB) consisting of a 3-hour
lecture on lung US (including instructions on differenti-
ating dynamic from static air bronchograms as well as
lung US findings consistent with bronchiolitis in chil-
dren under 2 years of age) and the recognition of disease
and potential errors, followed by a 4-hour practical hands-
on imaging session of normal models. The lung US was
carried out using a MyLab™25 Gold (Esaote, Genoa, Italy)
with a convex 2.5-6.6 MHz probe and a linear 7.5-12
MHz probe. The probes were placed perpendicularly, ob-
liquely and parallel to the ribs in the anterior, lateral and
posterior thorax (lower and upper) as described by Copetti
and Cattarossi [19], and were moved longitudinally and
transversely. The posterior thorax was scanned with the
patients in lateral decubitus and sitting positions. Alveolar
CAP was diagnosed in the presence of lung consolidation
with sonographic air bronchograms, whereas interstitial
CAP was diagnosed in the presence of B lines or an inter-
ruption of the normal course of the pleural line (superfi-
cial fluid alveologram). Mixed CAP was diagnosed in the
presence of data consistent with both alveolar and intersti-
tial CAP in the same patient. The presence of pleural effu-
sion was also evaluated in detail.
Statistical analysis
The performance of US in diagnosing CAP (i.e. its sensi-
tivity, specificity, and positive and negative predictive
values) was compared with that of CR, considered the
gold standard for CAP diagnosis in children according
to published guidelines [5-7]. The concordance of US
and CR in identifying specific types of CAP (i.e. alveolar,
mixed, non-alveolar) and pleural effusion was evaluated
using Cohen’s weighted kappa (k) statistics [20]. The dis-
crepancies between US and CR were assessed using mar-
ginal homogeneity Stuart-Maxwell statistics [21,22], which
are analogous to the McNemar chi-squared test for paired
data but can also be used for variables with more than
two categories. The analyses were made using Stata 13
software (Stata Corp., 2013).
Results
Forty-eight of the 103 enrolled children (56 males, 54.4%;
mean age ± standard deviation [SD] 5.6 ± 4.6 years) had
radiographically confirmed CAP. Table 1 shows the sensi-
tivity, specificity, and positive and negative predictive values
of US in comparison with CR. All of the studied variables
were higher than 94%. CR detected one case of CAP that
was missed by US, whereas there were three cases with
sonographic air bronchograms <1 cm detected at US, that
Table 1 Sensitivity (Se), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV) of lung
ultrasonography (US) vs chest radiography (CR) in diagnosing community- acquired pneumonia
Lung US Se (%) Sp (%) PPV (%) NPV (%)
CR Negative Positive (95% CI) (95% CI) (95% CI) (95% CI)
Negative 52 3 97.9 94.5 94.0 98.1
Positive 1 47 (88.9-99.9) (84.9-98.9) (83.5-98.7) (89.9-100)
CI confidence interval.
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ograms at US in the same lobe where physical examination
revealed rales at the auscultation.
Table 2 shows the CR and US results in diagnosing
specific types of CAP. The concordance between the
two methods was relatively good (k = 0.64). However, be-
yond the three US-positive/CR-negative cases mentioned
above, there were 17 cases with non-alveolar CAP at CR
that were diagnosed as mixed (4 cases) or alveolar (13
cases) using US. In addition, 5 mixed CAP cases were
diagnosed as alveolar by US. In general, US tender to
overdiagnose CAP or to err on the side of diagnosing an
alveolar CAP (25 cases in the upper right off-diagonal
cells vs 3 cases in the lower left cells, p = 0.0009 at the
marginal homeogeneity Stuart-Maxwell test).
Table 3 shows the CR and US results in diagnosing
specific types of CAP in different lung districts. Con-
cordance was moderate to good when evaluated with
the k statistics, but again in all of the studied anatomical
districts the type of lung lesion was differently identified
by US and CR.
Table 4 shows the CR and US results in diagnosing
pleural effusion. US identified a significantly higher num-
ber of cases in both the right and left pleural space.Discussion
The findings of this study confirm that lung US is a simple
and reliable imaging technique that is nearly as reliable as
CR in identifying the lung lesions that are diagnostic for
CAP, and also show that it is even more effective than CRTable 2 Comparison of chest radiography (CR) and lung
ultrasonography (US) results in diagnosing specific types
of community-acquired pneumonia
Lung US
CR Negative Interstitial Mixed Alveolar Total
Negative 52 - 3 - 55
Interstitial - 8 4 13 25
Mixed 1 - 6 5 12
Alveolar - 1 1 9 11
Total 53 9 14 27 103
Weighted Cohen’s kappa: 0.64 (p < 0.0001).
Marginal homogeneity (Stuart-Maxwell) test: p = 0.0009.
Concordant results in bold.in diagnosing pleural effusion [10-17]. These data further
support the recent recommendation of the International
Liaison Committee on Lung Ultrasound to use US in
pediatric patients with suspected CAP in order to reduce
antibiotic abuse [15].
US has a number of advantages: it is easy to do at a
child’s bedside, takes little time to perform and interpret
the results, allows a close follow-up, and avoids the use
of ionising radiation, which is particularly important in
pediatrics because children are at least four times more
sensitive than adults to the induction of cancer [23]. It
has also been recently shown that CR frequently identifies
acute bronchitis in the presence of signs and symptoms of
mild to moderate CAP [24,25]. As antibiotic treatment is
not recommended for children diagnosed as having bron-
chitis [5-7], the use of lung US in children with clinical
findings suggesting mild-to-moderate CAP could reduce
the abuse of antibiotics, thus overcoming one of the limi-
tations of CR. Furthermore, the lung US examinations
in our study were performed by a non-radiologist clin-
ician after only a short period of training, and the good
results in terms of overall efficiency in comparison with
CR highlight the fact that lung US could be easily used
in the outpatient setting to reduce antibiotic abuse and
CAP-associated costs, although further studies specifically
performed in the pediatric outpatient setting are needed.
However, the concordance of the US and CR data was
relatively limited in terms of the type of lung lesions
revealed, and this may have important implications when
it comes to prescribing antibiotics. A considerable number
of cases were defined alveolar CAP by US but non-alveolar
CAP by CR. In the traditional recommendations, most
cases of alveolar CAP are considered to be due to a typical
bacterial infection requiring beta-lactam antibiotic therapy,
whereas interstitial CAP is thought to be mainly due to
viruses that do not require antibiotics or atypical bac-
teria that require macrolides [5-7]. This discordant result
may have been due to the different limit for the CR detec-
tion of lung consolidation. Shah et al. have reported that
lung consolidations of ≤1 cm are undetectable by CR,
which remains negative or suggests moderate infiltration
resembling non-alveolar disease [17]. There were similar
significant differences when the site of lung damage sug-
gesting CAP was evaluated: the concordance of the two
methods was only moderate, thus confirming the difficulty
Table 3 Comparison of chest radiography (CR) and lung ultrasonography (US) results in diagnosing specific types of
community-acquired pneumonia (CAP) in different anatomical districts
Right lung, upper k = 0.54 (p < 0.0001) MH-SM p = 0.046
Lung US
CR Negative Interstitial Mixed Alveolar Total
Negative 75 3 2 - 80
Interstitial 5 5 2 1 13
Mixed - - 2 - 2
Alveolar 2 3 1 2 8
Total 82 11 7 3 103
Right lung, lower k = 0.59 (p < 0.0001) MH-SM p = 0.002
Lung US
CR Negative Interstitial Mixed Alveolar Total
Negative 65 1 1 1 68
Interstitial 7 4 1 0 12
Mixed - - 4 - 4
Alveolar 6 2 5 6 19
Total 78 7 11 7 103
Left lung, upper k = 0.55 (p < 0.0001) MH-SMp = 0.20
Lung US
CR Negative Interstitial Mixed Alveolar Total
Negative 82 6 1 1 90
Interstitial 3 7 1 - 11
Mixed - - 1 - 1
Alveolar - - 1 - 1
Total 85 13 4 1 103
Left lung, lower k = 0.63 (p < 0.0001) MH-SM p = 0.03
Lung US
CR Negative Interstitial Mixed Alveolar Total
Negative 68 2 1 1 72
Interstitial 5 5 1 1 12
Mixed - - 2 - 2
Alveolar 4 2 4 7 17
Total 77 9 8 9 103
MH-SM marginal homogeneity (Stuart-Maxwell) test.
Concordant pairs in bold.
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of CAP. Although this result may have been affected by
the experience of the physician performing the lung US,
further data are needed to confirm the role of US in
identifying the possible etiology of CAP and studying
the characteristics of lung involvement and their corre-
lations also with clinical findings.
Regarding the diagnosis of pleural effusion, US appeared
better than CR, but comparison has not been done with
CT scan which represents the gold standard for its evalu-
ation [26-28]. However, in comparison with CT, US
does not use inonising radiation and has significantly
lower costs.Although this study highlights new possibilities in diag-
nostic approach to pediatric CAP, it has some limits. First
of all, all patients were hospitalized, and no evaluation
on children managed in the outpatient setting is avail-
able. Moreover, despite a pre-study analysis has been
performed on the optimal sample size of patients and
significant differences have been observed, the number
of radiologically-confirmed CAP cases is not too high in
order to draw a definitive judgment on US’s utility. This
is also the reason for which the correlation between US
findings and laboratory data has not been done, but further
researches should evaluate this correlation. Furthermore,
the present research is not a multicentric study and further
Table 4 Comparison of chest radiography (CR) and
lung ultrasonography (US) results in diagnosing
pleural effusion
Pleural effusion, right k = 0.30 (p < 0.0001) MH-SM p= 0.0005
Lung US
CR Absent Present Total
Absent 88 12 100
Present 0 3 3
Total 88 15 103
Pleural effusion, left k = 0.16 (p = 0.02) MH-SM p= 0.004
Lung US
CR Absent Present Total
Absent 86 13 99
Present 2 2 4
Total 88 15 103
MH-SM marginal homogeneity (Stuart-Maxwell) test.
Concordant pairs in bold.
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tors in performing the lung US examinations.
Conclusion
US can be considered a useful means of diagnosing CAP
in all children admitted to an Emergency Department with
lower respiratory tract infection. However, its usefulness
in identifying the type of lung involvement is uncertain,
could be influenced by the operator’s learning curve, and
requires further evaluation before US can be considered
reliable enough to be used for making decisions concern-
ing antibiotic treatment in children with CAP.
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